The chief development officer of Corcept Therapeutics sold 20,000 shares of the biotech for $703,656 on Tuesday. The transaction was executed as a direct open-market sale of option shares; no indirect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results